Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
NKGen Biotech, Inc. (NKGN) had Return on Investments of -18.10% for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$6.31M |
|
-- |
|
-- |
|
$6.79M |
|
$-6.79M |
|
$13.39M |
|
$6.60M |
|
$6.60M |
|
$6.60M |
|
$6.60M |
|
$6.60M |
|
$6.60M |
|
$-6.79M |
|
$-6.46M |
|
29.13M |
|
41.33M |
|
$0.23 |
|
$0.15 |
|
| Balance Sheet Financials | |
$0.91M |
|
$13.58M |
|
$14.08M |
|
$14.99M |
|
$37.12M |
|
$10.60M |
|
$24.93M |
|
$62.05M |
|
$-47.05M |
|
$-47.05M |
|
$-47.05M |
|
35.72M |
|
| Cash Flow Statement Financials | |
$-13.93M |
|
$0.00M |
|
$13.89M |
|
$0.28M |
|
$0.24M |
|
$-0.04M |
|
$3.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
-0.29 |
|
-0.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.93M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.02% |
|
-14.02% |
|
44.00% |
|
|
Return on Investments |
-18.10% |
$-1.32 |
|
$-0.34 |
|
$-0.34 |
|